PLAT and intracerebral hemorrhage: Due to this limited intervention time, only about 3–5% of patients are eligible to receive tPA treatment (Fonarow et al., 2011) and 2–8% of that eligible population experience intracerebral hemorrhage as a consequence of receiving tPA (Miller et al., 2011).